Reply to “Comment on López-Yerena et al. ‘Absorption and Intestinal Metabolic Profile of Oleocanthal in Rats’ Pharmaceutics 2020, 12, 134”
Abstract
1. Introduction
2. Reply to the Comments
2.1. Purity of Oleocanthal and Biological Sample Analysis
2.2. Perfusion Technique
3. Conclusions
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Christophoridou, S.; Dais, P.; Tseng, A.L.-H.; Spraul, M. Separation and Identification of Phenolic Compounds in Olive Oil by Coupling High-Performance Liquid Chromatography with Postcolumn Solid-Phase Extraction to Nuclear Magnetic Resonance Spectroscopy (LC-SPE-NMR). J. Agric. Food Chem. 2005, 53, 4667–4679. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- De Medina, V.S.; Miho, H.; Melliou, E.; Magiatis, P.; Priego-Capote, F.; de Castro, M.D.L. Quantitative method for determination of oleocanthal and oleacein in virgin olive oils by liquid chromatography–tandem mass spectrometry. Talanta 2017, 162, 24–31. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Hazas, M.-C.L.D.L.; Piñol, C.; Macià, A.; Romero, M.-P.; Pedret, A.; Solà, R.; Rubió, L.; Motilva, M.-J. Differential absorption and metabolism of hydroxytyrosol and its precursors oleuropein and secoiridoids. J. Funct. Foods 2016, 22, 52–63. [Google Scholar] [CrossRef] [Scilit]
- Serra, A.; Rubió, L.; Borràs, X.; Macià, A.; Romero, M.-P.; Motilva, M.-J. Distribution of olive oil phenolic compounds in rat tissues after administration of a phenolic extract from olive cake. Mol. Nutr. Food Res. 2012, 56, 486–496. [Google Scholar] [CrossRef] [Scilit]
- Suárez, M.; Romero, M.-P.; Macià, A.; Valls, R.M.; Fernández, S.; Solà, R.; Casado, M.-J.M. Improved method for identifying and quantifying olive oil phenolic compounds and their metabolites in human plasma by microelution solid-phase extraction plate and liquid chromatography–tandem mass spectrometry. J. Chromatogr. B 2009, 877, 4097–4106. [Google Scholar] [CrossRef] [Scilit]
- Resch, V.; Seidler, C.; Chen, B.-S.; Degeling, I.; Hanefeld, U. On the Michael Addition of Water to α,β-Unsaturated Ketones Using Amino Acids. Eur. J. Org. Chem. 2013, 2013, 7697–7704. [Google Scholar] [CrossRef] [Scilit]
- Silva, S.; Garcia-Aloy, M.; Figueira, M.E.; Combet, E.; Mullen, W.; Ros, M. High Resolution Mass Spectrometric Analysis of Secoiridoids and Metabolites as Biomarkers of Acute Olive Oil Intake—An Approach to Study Interindividual Variability in Humans. Mol. Nutr. Food Res. 2018, 62, 1–11. [Google Scholar] [CrossRef] [Scilit]
- Orrego-Lagarón, N.; Vallverdú-Queralt, A.; Martínez-Huélamo, M.; Lamuela-Raventos, R.M.; Escribano-Ferrer, E. Metabolic profile of naringenin in the stomach and colon using liquid chromatography/electrospray ionization linear ion trap quadrupole-Orbitrap-mass spectrometry (LC-ESI-LTQ-Orbitrap-MS) and LC-ESI-MS/MS. J. Pharm. Biomed. Anal. 2016, 120, 38–45. [Google Scholar] [CrossRef] [Scilit]
- Ventura, G.; Calvano, C.D.; Abbattista, R.; Bianco, M.; De Ceglie, C.; Losito, I.; Palmisano, F.; Cataldi, T.R. Characterization of bioactive and nutraceutical compounds occurring in olive oil processing wastes. Rapid Commun. Mass Spectrom. 2019, 33, 1670–1681. [Google Scholar] [CrossRef] [Scilit]
- Kanakis, P.; Termentzi, A.; Michel, T.; Gikas, E.; Halabalaki, M.; Skaltsounis, A.-L. From Olive Drupes to Olive Oil. An HPLC-Orbitrap-based Qualitative and Quantitative Exploration of Olive Key Metabolites. Planta Med. 2013, 79, 1576–1587. [Google Scholar] [CrossRef] [Scilit]
- Taketani, M.; Shii, M.; Ohura, K.; Ninomiya, S.; Imai, T. Carboxylesterase in the liver and small intestine of experimental animals and human. Life Sci. 2007, 81, 924–932. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Griffin, B.T.; O’Driscoll, C. Drug Absorption Studies; Springer Science and Business Media LLC: Berlin/Heidelberg, Germany, 2007; pp. 34–76. [Google Scholar]
- Dahan, A.; Amidon, G.L. MRP2 mediated drug–drug interaction: Indomethacin increases sulfasalazine absorption in the small intestine, potentially decreasing its colonic targeting. Int. J. Pharm. 2010, 386, 216–220. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Dahan, A.; West, B.T.; Amidon, G.L. Segmental-dependent membrane permeability along the intestine following oral drug administration: Evaluation of a triple single-pass intestinal perfusion (TSPIP) approach in the rat. Eur. J. Pharm. Sci. 2009, 36, 320–329. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Zur, M.; Gasparini, M.; Wolk, O.; Amidon, G.L.; Dahan, A. The Low/High BCS Permeability Class Boundary: Physicochemical Comparison of Metoprolol and Labetalol. Mol. Pharm. 2014, 11, 1707–1714. [Google Scholar] [CrossRef] [Scilit]
- Incecayir, T.; Tsume, Y.; Amidon, G.L. Comparison of the Permeability of Metoprolol and Labetalol in Rat, Mouse, and Caco-2 Cells: Use as a Reference Standard for BCS Classification. Mol. Pharm. 2013, 10, 958–966. [Google Scholar] [CrossRef] [Scilit]
- Roos, C.; Dahlgren, D.; Sjögren, E.; Tannergren, C.; Abrahamsson, B.; Lennernäs, H. Regional Intestinal Permeability in Rats: A Comparison of Methods. Mol. Pharm. 2017, 14, 4252–4261. [Google Scholar] [CrossRef] [Scilit]
- Roos, C.; Dahlgren, D.; Berg, S.; Westergren, J.; Abrahamsson, B.; Tannergren, C.; Sjögren, E.; Lennernäs, H. In Vivo Mechanisms of Intestinal Drug Absorption from Aprepitant Nanoformulations. Mol. Pharm. 2017, 14, 4233–4242. [Google Scholar] [CrossRef] [Scilit]
- Sutton, S.C.; Rinaldi, M.T.S.; Vukovinsky, K.E. Comparison of the gravimetric, phenol red, and 14C-PEG-3350 methods to determine water absorption in the rat single-pass intestinal perfusion model. AAPS Pharmsci 2001, 3, 93–97. [Google Scholar] [CrossRef] [Scilit]
- Tuğcu-Demiröz, F.; Gonzalez-Alvarez, I.; Gonzalez-Alvarez, M.; Bermejo, M. Validation of phenol red versus gravimetric method for water reabsorption correction and study of gender differences in Doluisio’s absorption technique. Eur. J. Pharm. Sci. 2014, 62, 105–110. [Google Scholar] [CrossRef] [Scilit]
- Li, W.B.; Luo, B.F.; Wang, R.; Lu, H.; Wang, C.; Zhao, A.P.; Jia, Z.P. Changes of P-gp expression in rats’ small intestine and effects on uptake of levofloxacin after acute exposure to hypoxia. Yao xue xue bao = Acta Pharm. Sin. 2016, 51, 1412–1416. [Google Scholar]
- Volpe, D.A. Permeability classification of representative fluoroquinolones by a cell culture method. Aaps Pharmsci. 2004, 6, 1–6. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Dahan, A.; Wolk, O.; Agbaria, R. Provisional in-silico biopharmaceutics classification (BCS) to guide oral drug product development. Drug Des. Dev. Ther. 2014, 8, 1563–1575. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Rowland, M.; Tozer, T. Clinical Pharmacokinetics Pharmacodynamics: Concepts and Applications, 5th ed.; Williams & Wilkins: Philadelphia, PA, USA, 2019; p. 78. [Google Scholar]
- Komiya, I.; Park, J.; Kamani, A.; Ho, N.; Higuchi, W. Quantitative mechanistic studies in simultaneous fluid flow and intestinal absorption using steroids as model solutes. Int. J. Pharm. 1980, 4, 249–262. [Google Scholar] [CrossRef] [Scilit]
- Qusa, M.H.; Siddique, A.B.; Nazzal, S.; El Sayed, K.A. Novel olive oil phenolic (−)-oleocanthal (+)-xylitol-based solid dispersion formulations with potent oral anti-breast cancer activities. Int. J. Pharm. 2019, 569, 118596. [Google Scholar] [CrossRef] [Scilit]
- Siddique, A.B.; Ebrahim, H.; Mohyeldin, M.M.; Qusa, M.; Batarseh, Y.; Fayyad, A.; Tajmim, A.; Nazzal, S.; Kaddoumi, A.; El Sayed, K.A. Novel liquid-liquid extraction and self-emulsion methods for simplified isolation of extra-virgin olive oil phenolics with emphasis on (-)-oleocanthal and its oral anti-breast cancer activity. PLoS ONE 2019, 14, e0214798. [Google Scholar] [CrossRef] [Scilit]
- Morais, J.A.G.; Lobato, M.D.R. The New European Medicines Agency Guideline on the Investigation of Bioequivalence. Basic Clin. Pharmacol. Toxicol. 2010, 106, 221–225. [Google Scholar] [CrossRef] [Scilit]
- FDA. Waiver of in Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System; US Department of Health and Human Services Food and Drug Administration: Rockville, MD, USA, 2017. [Google Scholar]
- Brouwers, J.; Mols, R.; Annaert, P.P.; Augustijns, P. Validation of a differential in situ perfusion method with mesenteric blood sampling in rats for intestinal drug interaction profiling. Biopharm. Drug Dispos. 2010, 31, 278–285. [Google Scholar] [CrossRef] [Scilit]
- Lennernäs, H. Human jejunal effective permeability and its correlation with preclinical drug absorption models. J. Pharm. Pharmacol. 1997, 49, 627–638. [Google Scholar] [CrossRef] [Scilit]



Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
López-Yerena, A.; Vallverdú-Queralt, A.; Mols, R.; Augustijns, P.; Lamuela-Raventós, R.M.; Escribano-Ferrer, E. Reply to “Comment on López-Yerena et al. ‘Absorption and Intestinal Metabolic Profile of Oleocanthal in Rats’ Pharmaceutics 2020, 12, 134”. Pharmaceutics 2020, 12, 1221. https://doi.org/10.3390/pharmaceutics12121221
López-Yerena A, Vallverdú-Queralt A, Mols R, Augustijns P, Lamuela-Raventós RM, Escribano-Ferrer E. Reply to “Comment on López-Yerena et al. ‘Absorption and Intestinal Metabolic Profile of Oleocanthal in Rats’ Pharmaceutics 2020, 12, 134”. Pharmaceutics. 2020; 12(12):1221. https://doi.org/10.3390/pharmaceutics12121221
Chicago/Turabian StyleLópez-Yerena, Anallely, Anna Vallverdú-Queralt, Raf Mols, Patrick Augustijns, Rosa M. Lamuela-Raventós, and Elvira Escribano-Ferrer. 2020. "Reply to “Comment on López-Yerena et al. ‘Absorption and Intestinal Metabolic Profile of Oleocanthal in Rats’ Pharmaceutics 2020, 12, 134”" Pharmaceutics 12, no. 12: 1221. https://doi.org/10.3390/pharmaceutics12121221
APA StyleLópez-Yerena, A., Vallverdú-Queralt, A., Mols, R., Augustijns, P., Lamuela-Raventós, R. M., & Escribano-Ferrer, E. (2020). Reply to “Comment on López-Yerena et al. ‘Absorption and Intestinal Metabolic Profile of Oleocanthal in Rats’ Pharmaceutics 2020, 12, 134”. Pharmaceutics, 12(12), 1221. https://doi.org/10.3390/pharmaceutics12121221

